Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Delta 9 Cannabis Inc. (T:DN)

Business Focus: Pharmaceuticals (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for DN within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Apr 01, 2024 06:00 ET
Delta 9 Reports Year-end Financials for 2023
WINNIPEG, MB – TheNewswire - April 1, 2024 – DELTA 9 CANNABIS INC. (TSX: DN) (OTC: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month period and year ending December 31, 2023.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.44
--
--
Price to Sales - TTM
0.08
3.41
3.83
Price to Book - most recent quarter
--
2.91
2.08
Price to Cash Flow per share - TTM
--
6.99
9.68
Price to Free Cash Flow per share - TTM
1.60
19.38
14.80
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Apr 15, 202417,462-131,832
Mar 31, 2024149,294142,074
Mar 15, 20247,220-44,186
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Delta 9 Cannabis Inc. is a Canada-based vertically integrated cannabis company. The Company operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices, and Business to Business. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis growing pods to other businesses. Its cannabis products include dried cannabis and pre-rolled joints. Its edibles and vapes include vape pens and concentrates, edibles, and drinkables. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates a 95,000-square-foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. It also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. It is focused on producing and selling cannabis oils, extracts, and derivative products.

See business summary

 

Twitter

Search (past week) for $DN.CA

  • No tweets found